Identification of dithiolethiones with better chemopreventive properties than oltipraz

Carcinogenesis

Volumn 19, Issue 9, 1998, Pages 1609-1615

  Maxuitenko, Yulia Y ^a,c   Libby, Adam H ^a   Joyner, H Howard ^a,d   Curphey, Thomas J ^a   MacMillan, Denise L ^a   Kensler, Thomas W ^b   Roebuck, B D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d MeadWestvaco Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; DITHIOL DERIVATIVE; GLUTATHIONE TRANSFERASE; OLTIPRAZ; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL EXPERIMENT; ARTICLE; BILE DUCT; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMOPROPHYLAXIS; DRUG ACTIVITY; DRUG IDENTIFICATION; ENZYME ACTIVITY; ENZYME INDUCTION; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

AFLATOXIN B1; ANIMALS; ANTICARCINOGENIC AGENTS; ENZYME INDUCTION; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PYRAZINES; RATS; RATS, INBRED F344;

EID: 0031684074     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.9.1609     Document Type: Article

References (35)

1. Kelloff, G.J., Boone, C.W., Crowell, J.A., Steele, V.E., Lubet, R. and Sigman, C.C. (1994) Chemopreventive drug development: perspectives and progress. Cancer Epidemiol. Biomarkers Prev., 3, 85-98.
2. Dimitrov, N.V., Bennett, J.L., McMillan, J., Perloff, M., Leece, C.M. and Malone, W. (1992) Clinical pharmacology studies of oltipraz - a potential chemopreventive agent. Invest. New Drugs, 10, 289-298.
3. Gupta, E., Olopade, O.I., Ratain, M.J., Mick, R., Baker, T.M., Berezin, F.K., Benson, A.B. and Dolan, M.E. (1995) Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Clin. Cancer Res., 1, 1133-1138.
4. Kensler, T.W. et al. (1998) Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol. Biomarkers Prev., 7, 127-134.
5. Jacobson, L.P. et al. (1997) Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. Cancer Epidemiol. Biomarkers Prev., 6, 257-265.
6. Archer, S. (1985) The chemotherapy of schistosomiasis. Annu. Rev. Pharmacol. Toxicol., 25, 485-508.
7. Häusler, R. and Ritschard, J. (1979) Clinical study with a sialagogue drug (Sulfarlem S 25 = TTPT) in the treatment of xerostomia. Rev. Suisse Praxis Med., 68, 1063-1066.
8. Ansher, S.S., Dolan, P. and Bueding, E. (1986) Biochemical effects of dithiolthiones. Food Chem. Toxicol., 25, 405-415.
9. Prochaska, H.J., De Long, M.J. and Talalay, P. (1985) On the mechanism of induction of cancer protective enzymes: a unifying proposal. Proc. Natl Acad. Sci. USA. 82, 8232-8236.
10. Buetler, T.M., Gallagher, E.P., Wang, C., Stahl, D.L., Hayes, J.D. and Eaton, D.L. (1995) Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol. Appl. Pharmacol., 135, 45-57.
11. Ansher, S.S., Dolan, P. and Bueding, E. (1983) Chemoprotective effects of two dithiolthiones and of butylhydroxyanisole against carbon tetrachloride and acetaminophen toxicity. Hepatology, 3, 932-935.
12. Davies, M.H., Schamber, G.J. and Schnell, R.C. (1987) Role of glutathione in oltipraz-induced protection against acetaminophen and allyl alcohol hepatotoxicity in the male hamster. Toxicologist, 7, 219.
13. 1 in the rat. Toxicol. Appl. Pharmacol., 93, 442-451.
14. 1-induced hepatic toxicity as a short term screen of cancer chemopreventive dithiolethiones. Fundam. Appl. Toxicol., 32, 250-259.
15. Kensler, T.W., Egner, P.A., Dolan, P.M., Groopman, J.D. and Roebuck, B.D. (1987) Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res., 47, 4271-4277.
16. 1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Cancer Res., 51, 5501-5506.
17. 1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Carcinogenesis, 14, 2423-2425.
18. Curphey, T.J. and Joyner, H.H. (1993) A new synthesis of 3H-1,2-dithiole-3-thiones. Tetrahedron Lett., 34, 3703-3706.
19. Curphey, T.J. and Joyner, H.H. (1993) Synthesis of 3H-1,2-dithiole-3-thiones by a novel oxidative cyclization. Tetrahedron Lett., 34, 7231-7234.
20. Egner, P.A., Kensler, T.W., Prestera, T., Talalay, P., Libby, A.H., Joyner, H.H. and Curphey, T.J. (1994) Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis, 15, 177-181.
21. Kensler, T.W., Groopman, J.D., Eaton, D.L., Curphey, T.J. and Roebuck, B.D. (1992) Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis, 13, 95-100.
22. Habig, W.H., Pabst, M.J. and Jakoby, W.B. (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139.
23. Benson, A.M., Hunkeler, M.J. and Talalay, P. (1980) Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl Acad. Sci. USA, 77, 5216-5220.
24. 1. Toxicol. Lett., 61, 233-242.
25. Sugie, S., Tanaka, J., Mori, H. and Reddy, B.S. (1993) Effect of restricted caloric intake on the development of the azoxymethane-induced glutathione S-transferase placental form positive hepatocellular foci in male F344 rats. Cancer Lett., 15, 67-73.
26. Hikita, H., Vaughan, J. and Pitot, H.C. (1997) The effect of two periods of short-term fasting during the promotion stage of hepatocarcinogenesis in rats: the role of apoptosis and cell proliferation. Carcinogenesis, 18, 159-166.
27. Kensler, T.W., Styczynski, P., Groopman, J., Helzlsouer, K., Curphey, T., Maxuitenko, Y. and Roebuck, B.D. (1992) Mechanisms of chemoprotection by oltipraz. J. Cell. Biochem., 161 (suppl.), 167-172.
28. Pugh, T.D., King, J.H., Koen, H., Nychka, D., Chover, J., Wahba, G., He, Y. and Goldfarb, S. (1983) Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cancer Res., 43, 1261-1268.
29. 1 in rats. Br. J. Cancer, 18, 756-762.
30. Edds, G.T. (1973) Acute aflatoxicosis: a review. J. Am. Vet. Med. Assoc., 162, 304-309.
31. Cullen, J.M. and Newberne, P.M. (1994) Acute hepatotoxicity of aflatoxins. In Eaton, D.L. and Groopman, J.D. (eds) The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. Academic Press, Boston, MA, pp. 3-26.
32. Talalay, P., Fahey, J.W., Holtzclaw, W.D., Prestera, T. and Zhang, Y. (1995) Chemoprotection against cancer by phase 2 enzyme induction. Toxicol. Lett., 82/83, 173-179.
33. Kim, W. and Gates, K.S. (1997) Evidence for thiol-dependent production of oxygen radicals by 4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione (oltipraz) and 3H-1,2-dithiole-3-thione: possible relevance to the anticarcinogenic properties of 1,2-dithiole-3-thiones. Chem. Res. Toxicol., 10, 296-301.
34. Burgot, G., Bona, M., Christen, M.O. and Burgot, J.L. (1996) First relationships between detoxication properties of some 1,2-dithiole-3-thiones and their log P. Int. J. Pharmaceutics, 129, 295-299.
35. Maxuitenko, Y.Y., Curphey, T.J. and Roebuck, B.D. (1997) Identification of dithiolethione analogs more potent than oltipraz for chemoprevention of liver cancer. Proc. Am. Assoc. Cancer Res., 38, 363.